anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
CG Oncology · pitchdeck

CG Oncology | IPO Presentation Deck | 45 slides

45 pages · 5 arc beats · 2 loops

Pitchdeck Download JSON
Unlock

CG Oncology | IPO Presentation Deck | 45 slides

CG Oncology · 2024-03
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
— No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.
—

Deck intelligence map

5
coverage by narrative range · generated from this deck JSON
Narrative range 9 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Problem 1 slides 100% 1/1 slides 100% 1/1 slides · 9 hits
— 0/1 slides
100% 1/1 slides 100% 1/1 slides 100% 1/1 slides 100% 1/1 slides Solution 4 slides 100% 4/4 slides 100% 4/4 slides · 21 hits
— 0/4 slides
25% 1/4 slides 75% 3/4 slides 100% 4/4 slides
— 0/4 slides
Market Size 1 slides 100% 1/1 slides 100% 1/1 slides · 5 hits
— 0/1 slides
100% 1/1 slides
— 0/1 slides
100% 1/1 slides 100% 1/1 slides Traction 2 slides 100% 2/2 slides 100% 2/2 slides · 11 hits
— 0/2 slides
— 0/2 slides
— 0/2 slides
100% 2/2 slides 100% 2/2 slides Team 1 slides 100% 1/1 slides 100% 1/1 slides · 8 hits
— 0/1 slides
— 0/1 slides
— 0/1 slides
100% 1/1 slides
— 0/1 slides

Slide inventory

45
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detail
02
other
Open slide detail
03
This is a standard IPO 'deal terms' slide.other
Open slide detail
04
The slide uses a grid layout for five executive profiles, each including a headshot, title, brief bio, and relevant company logos.other
Open slide detailBeat · Team
05
inspire_vision
Open slide detail
06
summarize
Open slide detail
07
Uses a comparative diagram to illustrate the biological mechanism.present_solution
Open slide detailBeat · Solution
08
The slide uses a circular process diagram overlaid on a cross-section of a bladder to explain the treatment steps.present_solution
Open slide detailBeat · Solution
09
Uses a before-after framing to explain the mechanism of action for the DDM surfactant.present_solution
Open slide detailBeat · Solution
10
The slide uses a biological process flow to explain the therapeutic mechanism.present_solution
Open slide detailBeat · Solution
11
The slide uses a three-column layout to categorize the problem into prevalence, clinical challenges, and patient profile.frame_problem
Open slide detailBeat · ProblemLoop · Cost Of Inaction
12
The diagram shows the progression of tumor invasion through the bladder wall layers (Lamina Propria, Inner Muscle, Deep Muscle).size_opportunity
Open slide detailBeat · Market SizeLoop · Cost Of Inaction
13
The slide uses a process flow that transitions into a decision tree/matrix based on risk levels.present_framework
Open slide detailLoop · Cost Of Inaction
14
The slide highlights the regulatory environment as a key driver for development, citing specific FDA definitions and successful approvals.argue_timing
Open slide detailLoop · Cost Of Inaction
15
The slide uses a hierarchical tree structure to map clinical trials to specific patient segments (Intermediate vs High Risk, BCG-naïve/exposed/unresponsive).decompose_segments
Open slide detailLoop · Cost Of Inaction
16
Includes FDA Fast Track and Breakthrough Therapy designations.plan_implementation
Open slide detailLoop · Cost Of Inaction
17
BOND-003 study data.analyze_data
Open slide detailLoop · Cost Of Inaction
18
Efficacy data cutoff as of October 5, 2023. Footnote indicates some patients excluded from 6-month assessment.show_traction
Open slide detailBeat · TractionLoop · Cost Of Inaction
19
The slide uses a swimmer plot to visualize individual patient response durations, including complete response, recurrence, and reinduction events.show_traction
Open slide detailBeat · TractionLoop · Cost Of Inaction
20
BOND-003 clinical trial safety data.analyze_data
Open slide detailLoop · Cost Of Inaction
21
The slide explicitly notes that these are not head-to-head studies.compare_peers
Open slide detailLoop · Cost Of Inaction
22
The slide uses a process-flow style layout to define the clinical trial parameters.present_framework
Open slide detailLoop · Cost Of Inaction
23
The slide uses a swimmer plot to visualize patient-level clinical trial data.show_traction
Open slide detailLoop · Cost Of Inaction
24
The table lists specific medical conditions (Preferred Terms) and their occurrence rates across 35 patients.analyze_data
Open slide detailLoop · Cost Of Inaction
25
The slide uses a detailed comparison table to highlight the competitive positioning of CG Oncology's CORE-001 trial against other industry players.compare_peers
Open slide detailLoop · Cost Of Inaction
26
PIVOT-006 trial design slide.plan_implementation
Open slide detailLoop · Cost Of Inaction
27
The slide uses a process-flow layout to define the clinical trial structure.present_framework
Open slide detailLoop · Cost Of Inaction
28
The slide uses a hierarchical tree structure to map patient risk categories to specific clinical trial programs (PIVOT-006, CORE-008, BOND-003, CORE-001).size_opportunity
Open slide detailLoop · Cost Of Inaction
29
CMC stands for Chemistry, Manufacturing, and Controls.plan_implementation
Open slide detailLoop · Cost Of Inaction
30
The slide uses a grid of four headshots with biographical details and company logos for each member.other
Open slide detailLoop · Cost Of Inaction
31
The slide uses a circular process flow graphic to represent a sequential commercialization strategy.plan_implementation
Open slide detailLoop · Cost Of Inaction
32
The diagram uses a hub-and-spoke model to show how various commercial roles interact with the central customer entities (LUGPA and Hospitals).plan_implementation
Open slide detailLoop · Cost Of Inaction
33
The slide uses a grid-based timeline layout to map specific clinical trial milestones (stars) against time periods.plan_implementation
Open slide detailLoop · Cost Of Inaction
34
summarize
Open slide detailLoop · Cost Of Inaction
35
This is a standard contact/footer slide often found at the end of a pitch deck.front_matter
Open slide detailLoop · Cost Of Inaction
36
frame_problem
Open slide detailLoop · Cost Of Inaction
37
The slide provides a breakdown of intellectual property and regulatory protections for the company's product.cite_precedent
Open slide detailLoop · Cost Of Inaction
38
The slide uses a genetic map comparison to explain the mechanism of action.present_solution
Open slide detailLoop · Cost Of Inaction
39
The slide uses a color-coded matrix to segment the patient population by risk profile.size_opportunity
Open slide detailLoop · Cost Of Inaction
40
The slide uses a split-screen layout to frame the problem from two angles: supply-side shortage and clinical-side risk.frame_problem
Open slide detailLoop · Cost Of Inaction
41
The slide uses a hierarchical flow chart to categorize patient populations for clinical trial consistency.present_framework
Open slide detail
42
The slide compares monotherapy vs combination therapy clinical trial data.compare_peers
Open slide detail
43
The slide explicitly notes that these are not head-to-head studies and differences in study design exist.compare_peers
Open slide detail
44
The slide highlights the safety profile, emphasizing that most AEs are low-grade and transient.analyze_data
Open slide detail
45
The slide uses a structured table format to categorize achievements into three pillars: Clinical, Corporate, and Financing.summarize
Open slide detail